Table C.15.
Result for the incidence of hepatocellular adenomas and carcinomas reported by Moser et al. (2009) using model averaging
| Model | Number of parameters | Log‐likelihood | AIC | BMD | BMDL | BMDU | Converged | Accepted AIC |
|---|---|---|---|---|---|---|---|---|
| Null | 1 | −148.52 | 299.04 | NA | NA | NA | Yes | |
| Full | 6 | −114.48 | 240.96 | NA | NA | NA | Yes | |
| Logistic | 2 | −114.94 | 233.88 | 2.03 | 1.71 | 2.41 | Yes | Yes |
| Probit | 2 | −115.09 | 234.18 | 1.87 | 1.59 | 2.21 | Yes | Yes |
| Log‐logistic | 3 | −114.65 | 235.30 | 2.78 | 1.76 | 3.87 | Yes | Yes |
| Log‐probit | 3 | −114.62 | 235.24 | 2.85 | 1.89 | 3.88 | Yes | Yes |
| Weibull | 3 | −114.73 | 235.46 | 2.62 | 1.53 | 3.88 | Yes | Yes |
| Gamma | 3 | −114.66 | 235.32 | 2.76 | 1.65 | 3.88 | Yes | Yes |
| Two‐stage | 3 | −114.82 | 235.64 | 2.34 | 2.02 | 2.77 | No | Yes |
AIC: Akaike information criterion; BMD: benchmark dose; BMDL: benchmark dose lower confidence limit; BMDU: benchmark dose upper confidence limit.